Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Dolby Laboratories, Inc. (DLB)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.35B | $1.27B | $1.30B | $1.25B | $1.28B | $1.16B | $1.24B | $1.05B | $1.08B | $1.03B | $970.6M | $960.2M | $909.7M | $933.0M | $961.1M | $922.7M | $719.5M | $640.2M |
| Gross profit | $1.19B | $1.13B | $1.15B | $1.11B | $1.15B | $1.02B | $1.08B | $927.0M | $961.6M | $916.8M | $875.8M | $890.0M | $813.0M | $841.0M | $849.9M | $790.9M | $654.7M | $572.5M |
| Research & development | $261.8M | $263.7M | $271.5M | $261.2M | $253.6M | $239.0M | $237.9M | $236.8M | $233.3M | $219.6M | $201.3M | $183.1M | $168.7M | $140.1M | $123.9M | $105.0M | $81.5M | $77.5M |
| Operating expenses | $924.0M | $874.9M | $931.4M | $905.8M | $806.8M | $796.6M | $823.7M | $743.5M | $714.5M | $685.0M | $662.6M | $616.3M | $567.7M | $479.0M | $420.2M | $361.5M | $291.1M | $285.7M |
| Operating income | $265.0M | $258.3M | $215.8M | $206.6M | $344.4M | $218.7M | $257.1M | $183.5M | $247.1M | $231.8M | $213.2M | $273.7M | $245.3M | $362.0M | $429.7M | $429.4M | $363.7M | $286.8M |
| EBITDAderived | $352.8M | $333.9M | $298.3M | $295.1M | $440.3M | $309.6M | $342.2M | $264.8M | $331.4M | $316.9M | $282.4M | $327.0M | $298.5M | $405.9M | $473.7M | $464.3M | $392.4M | $311.6M |
| Net income | $255.0M | $261.8M | $200.7M | $184.1M | $310.2M | $231.4M | $255.2M | $41.7M | $206.5M | $185.9M | $181.4M | $206.1M | $189.3M | $264.3M | $309.3M | $283.4M | $243.0M | $199.5M |
| Basic EPSper diluted share | $2.66 | $2.74 | $2.10 | $1.84 | $3.07 | $2.30 | $2.51 | $0.40 | $2.03 | $1.85 | $1.77 | $2.02 | $1.86 | $2.47 | $2.78 | $2.50 | $2.15 | $1.79 |
| Diluted EPSper diluted share | $2.62 | $2.69 | $2.05 | $1.81 | $2.97 | $2.25 | $2.44 | $0.39 | $2.00 | $1.81 | $1.75 | $1.99 | $1.84 | $2.46 | $2.75 | $2.46 | $2.11 | $1.74 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026Form 4 · 10b5-1 | Couling John DSVP, Entertainment | SellClass A Common Stock | 508 | $56.16 | $28.5K | 118.7K |
| Jun 1, 2026Form 4 · 10b5-1 | Couling John DSVP, Entertainment | SellClass A Common Stock | 7.2K | $55.59 | $397.9K | 119.2K |
| May 22, 2026Form 4 | Pendleton ToddSVP, Chief Marketing Officer | SellClass A Common Stock | 11.9K | $54.55 | $647.8K | 41.5K |
| May 15, 2026Form 4 · 10b5-1 | Revankar ShriramSVP, Advanced Technology Group | SellClass A Common Stock | 3.0K | $54.90 | $164.7K | 80.6K |
| May 12, 2026Form 4 · 10b5-1 | Park Robert JSVP & Chief Financial Officer | SellClass A Common Stock | 391 | $57.35 | $22.4K | 81.5K |